Adderall XR and Processing Speed in Multiple Sclerosis (MS)

Clinical trial NCT01667484 · COMPLETED

Trial details

NCT number: NCT01667484
Sponsor: London Health Sciences Centre
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Impaired Processing Speed Cognitive Impairment Multiple Sclerosis

Start date: 2012-09-01
Primary completion: 2013-02-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.